Hypermarcas (OTCMKTS:HYPMY) Share Price Passes Below Fifty Day Moving Average – Here’s What Happened

Shares of Hypermarcas (OTCMKTS:HYPMYGet Free Report) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $4.37 and traded as low as $4.00. Hypermarcas shares last traded at $4.1125, with a volume of 736 shares traded.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Hypermarcas has a consensus rating of “Buy”.

Check Out Our Latest Report on Hypermarcas

Hypermarcas Trading Up 1.8%

The company’s 50-day simple moving average is $4.34 and its 200-day simple moving average is $4.40. The stock has a market capitalization of $2.94 billion, a price-to-earnings ratio of 8.69 and a beta of 0.71.

Hypermarcas (OTCMKTS:HYPMYGet Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.10 EPS for the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. The company had revenue of $383.13 million for the quarter. On average, equities research analysts expect that Hypermarcas will post 0.53 earnings per share for the current fiscal year.

About Hypermarcas

(Get Free Report)

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.

Further Reading

Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.